Randomized trial investigates exosomal METTL3's role in M1 macrophage polarization, suggesting new immunotherapy targets.
Objective Macrophage polarization and function are regulated by epigenetic mechanisms and microRNAs transported by exosomes; however, the specific mechanisms are not clear yet. The study aims to investigate whether exosomes regulate miR-155-5p maturation through methyltransferase-like 3 (METTL3)-mediated N6-methyladenosine (m6A) modification, thereby driving M1 macrophage polarization and providing potential targets for inflammation and tumor immunotherapy.Method THP-1 cells were differentiated into M0 macrophages by PMA and subsequently polarized to the M1 phenotype with LPS and IFN-γ. Exosomes were extracted from culture supernatants using ultracentrifugation, and identified by dynamic light scattering (DLS), transmission electron microscopy (TEM), and western blotting (WB). Genes for overexpression or knockdown of METTL3/miR-155-5p were loaded into M0 exosomes, respectively, and M0-exos were then used to deliver them to recipient macrophages or injected into mice.Results Dot blot analysis showed an increase in m6A modification levels in the OE-METTL3 group. Flow cytometry (FCM), Enzyme-linked immunosorbent assay (ELISA), RT-qPCR, and WB results indicated that the OE-METTL3 group exhibited significantly elevated expression of M1 macrophage markers CD86, iNOS and HLA-DR, cytokines IL-1β, IL-6, TNF-α, and IL-18, signaling molecules NLRP3, TLR4, and caspase-1, whereas the expression of M2 macrophage markers CD206, CD163, Arg-1, IL-10 and TGF-β was decreased. The SI-METTL3 group showed the opposite trends. Further results demonstrated that miR-155-5p was correspondingly upregulated or downregulated. Additional intervention with miR-155-5p confirmed its regulatory effect on m6A modification and M1 polarization (p < 0.05). In vivo experiments yielded consistent results.Conclusion Exosomes promote miR-155-5p maturation through METTL3-mediated m6A modification, activate the NLRP3/TLR4/caspase-1 signaling pathway, drive M1 macrophage polarization, and exacerbate inflammatory responses. This research may provide novel potential targets for inflammation and tumor immunotherapy.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: